Tony F. Lai

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide data.

Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide data.

Journal: Antimicrobial agents and chemotherapy

Published: May 12, 2026

Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach.

Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach.

Journal: Antimicrobial agents and chemotherapy

Published: July 23, 2025

Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.

Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.

Journal: The Lancet regional health. Western Pacific

Published: July 01, 2025

Retrospective evaluation of a vancomycin dosing bundle in paediatric intensive care.

Retrospective evaluation of a vancomycin dosing bundle in paediatric intensive care.

Journal: International journal of antimicrobial agents

Published: June 05, 2025

Safe and effective use of vancomycin.

Safe and effective use of vancomycin.

Journal: Australian prescriber

Published: May 09, 2025

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data and key evidence gaps.

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data and key evidence gaps.

Journal: The Lancet regional health. Western Pacific

Published: January 22, 2025

Relationship between sputum bacterial load and lung function in children with cystic fibrosis receiving tobramycin.

Relationship between sputum bacterial load and lung function in children with cystic fibrosis receiving tobramycin.

Journal: Respiratory medicine

Published: December 18, 2024

Caffeine effect on myocardial perfusion scintigraphy.

Caffeine effect on myocardial perfusion scintigraphy.

Journal: Journal of medical imaging and radiation sciences

Published: April 30, 2024

Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review.

Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review.

Journal: The Journal of antimicrobial chemotherapy

Published: October 12, 2023

Exploring the advancements of Australian OPAT.

Exploring the advancements of Australian OPAT.

Journal: Therapeutic advances in infectious disease

Published: June 05, 2023

A multicentre, retrospective audit of fosfomycin use for urinary tract infections in Australian children and adolescents.

A multicentre, retrospective audit of fosfomycin use for urinary tract infections in Australian children and adolescents.

Journal: The Journal of antimicrobial chemotherapy

Published: December 12, 2022

LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring.

LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring.

Journal: International journal of antimicrobial agents

Published: November 09, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026